MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis

Not Applicable
Recruiting
Conditions
Liver Cirrhosis
Spontaneous Bacterial Peritonitis
Interventions
Biological: 20% High Dose Albumin
Other: Standard Medical Treatment
Biological: 20% Reduced Dose Albumin
First Posted Date
2023-09-07
Last Posted Date
2024-08-09
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
300
Registration Number
NCT06026267
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Not Applicable
Not yet recruiting
Conditions
Hepatic Osteodystrophy
Liver Cirrhosis
Interventions
First Posted Date
2023-09-01
Last Posted Date
2023-09-01
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
80
Registration Number
NCT06022237
Locations
🇮🇳

Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Efficacy & Safety of Pigtail Catheter Drainage Versus Need Based Thoracocentesis for Recurrent Hepatic Hydrothorax.

Not Applicable
Not yet recruiting
Conditions
Hepatic Hydrothorax
Interventions
Procedure: Pigtail Catheter
Procedure: Large Volume Thoracocentesis
First Posted Date
2023-08-23
Last Posted Date
2023-08-23
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
70
Registration Number
NCT06007820
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis

Not yet recruiting
Conditions
Decompensated Cirrhosis
Interventions
Other: No intervention
First Posted Date
2023-07-21
Last Posted Date
2023-07-21
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
55
Registration Number
NCT05956197
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).

Not Applicable
Not yet recruiting
Conditions
Decompensated Cirrhosis
Interventions
Biological: Albumin
Other: Standard of Care
First Posted Date
2023-07-10
Last Posted Date
2023-07-10
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
120
Registration Number
NCT05937048
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.

Not Applicable
Not yet recruiting
Conditions
NAFLD Cirrhosis
Interventions
Other: Standard of Care
First Posted Date
2023-05-08
Last Posted Date
2023-05-08
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
144
Registration Number
NCT05849220
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Incidence and Risk Factors of Prolonged Post-Operative Mechanical Ventilation

Not yet recruiting
Conditions
Pediatric Liver Transplantation
First Posted Date
2023-04-24
Last Posted Date
2023-04-24
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
60
Registration Number
NCT05825703
Locations
🇮🇳

ILBS, New Delhi, India

Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.

Not Applicable
Not yet recruiting
Conditions
Liver Failure, Acute
Interventions
First Posted Date
2023-03-21
Last Posted Date
2023-03-21
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
32
Registration Number
NCT05778461
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, India

Effect of Exercise Based Regimen on Frailty in Children With Liver Disease

Not Applicable
Completed
Conditions
Liver Diseases
Interventions
Other: 12 weeks exercise
Other: Standard Medical Treatment
First Posted Date
2023-03-15
Last Posted Date
2025-01-08
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
46
Registration Number
NCT05770284
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.

Not Applicable
Completed
Conditions
Portal Hypertension
Interventions
First Posted Date
2023-03-14
Last Posted Date
2025-01-08
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
40
Registration Number
NCT05767229
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath